Female Patients With Myofascial Pain Syndrome (MPS) Related to Upper Trapezius Active Trigger Points (TP) Clinical Trial
NCT number | NCT03949010 |
Other study ID # | KSCT&KMIT |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | December 2013 |
Est. completion date | December 2014 |
Verified date | May 2019 |
Source | Istanbul University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
To investigate the effectiveness of muscle inhibition and space correction techniques of kinesiotaping (KT) method; on pain, functional status and quality of life in female patients with myofascial pain syndrome (MPS) related to upper trapezius active trigger points (TP) in comparison to control group and to determine the advantage of each technique over another.
Status | Completed |
Enrollment | 93 |
Est. completion date | December 2014 |
Est. primary completion date | December 2014 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 18 Years to 45 Years |
Eligibility |
Inclusion Criteria: - being female - being aged between 18 and 45 years old - not being in menopausal period - having pain in upper trapezius region - determining a taut band in examination - having at least one active TP in this taut band - the pain produced by palpation of this TP is the pain that the patient complains - painfull restriction of cervical lateral flexion - having pain score 4 or more according to NRS - signing informed consent. Exclusion Criteria: - having major surgery or trauma related to the musculoskeletal system (primarily including the spine and upper extremity) - having any operative history including the head and neck region - having a neuromuscular disease - having an active rheumatic disease - having a systemic disease (diabetes, hypothyroidism, infection, malignancy...) - having any pathology related to musculoskeletal diseases -especially including the cervical region- (cervical discopathy, cervical spondylosis, pathologies related to shoulder joint and surrounding soft tissues, scoliosis, kyphosis, limb length discrepancy, polio sequelae, developmental hip dysplasia...) - having serious psychological problems (having score of 30 or more from Beck Depression Inventory) - being obese (Body Mass Index=30 kg/m2) - having allergy to kinesiotapes |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Dilsad Sindel |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change in pain related to myofascial pain syndrome due to upper trapezius active trigger points from baseline to first, second and six weeks | Pain intensity mesaurement via Numerical Rating Scale, range between 0 to 10, higher scores indicating more pain intensity | Initial assessment, First week, second week, sixth week | |
Primary | Change in disability related to myofascial pain syndrome due to upper trapezius active trigger points from baseline to second and six weeks | Functional status measurement via Neck Disability Index | Initial assessment, second week, sixth week | |
Primary | Change in quality of life affected by myofascial pain syndrome due to upper trapezius active trigger points from baseline to second and six weeks | Quality of life measurement via Short Form-36 | Initial assessment, second week, sixth week |